Addressing Barriers to the Development and Adoption of Rapid Diagnostic Tests in Global Health

Nanobiomedicine

Volumn 2, Issue , 2015, Pages

  Miller, Eric ^a   Sikes, Hadley D ^a  

^a USA   (United States)

Author keywords

global health; immunochromatography; infectious disease; point of care; Rapid diagnostic tests

Indexed keywords

EID: 85027967904     PISSN: None     EISSN: 18495435     Source Type: Journal    
DOI: 10.5772/61114     Document Type: Review

References (137)

1. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Barker-Collo S, Bartels DH, Bell ML, Benjamin EJ, Bennett D, Bhalla K, Bikbov B, Abdulhak Bin A, Birbeck G, Blyth F, Bolliger I, Boufous S, Bucello C, Burch M, Burney P, Carapetis J, Chen H, Chou D, Chugh SS, Coffeng LE, Colan SD, Colquhoun S, Colson KE, Condon J, Connor MD, Cooper LT, Corriere M, Cortinovis M, de Vaccaro KC, Couser W, Cowie BC, Criqui MH, Cross M, Dabhadkar KC, Dahodwala N, De Leo D, Degenhardt L, Delossantos A, Denenberg J, Des Jarlais DC, Dharmaratne SD, Dorsey ER, Driscoll T, Duber H, Ebel B, Erwin PJ, Espindola P, Ezzati M, Feigin V, Flaxman AD, Forouzanfar MH, Fowkes FGR, Franklin R, Fransen M, Freeman MK, Gabriel SE, Gakidou E, Gaspari F, Gillum RF, Gonzalez-Medina D, Halasa YA, Haring D, Harrison JE, Havmoeller R, Hay RJ, Hoen B, Hotez PJ, Hoy D, Jacobsen KH, James SL, Jasrasaria R, Jayaraman S, Johns N, Karthikeyan G, Kassebaum N, Keren A, Khoo J-P, Knowlton LM, Kobusingye O, Koranteng A, Krishnamurthi R, Lipnick M, Lipshultz SE, Ohno SL, Mabweijano J, MacIntyre MF, Mallinger L, March L, Marks GB, Marks R, Matsumori A, Matzopoulos R, Mayosi BM, McAnulty JH, McDermott MM, McGrath J, Mensah GA, Merriman TR, Michaud C, Miller M, Miller TR, Mock C, Mocumbi AO, Mokdad AA, Moran A, Mulholland K, Nair MN, Naldi L, Narayan KMV, Nasseri K, Norman P, O'Donnell M, Omer SB, Ortblad K, Osborne R, Ozgediz D, Pahari B, Pandian JD, Rivero AP, Padilla RP, Perez-Ruiz F, Perico N, Phillips D, Pierce K, Pope CA, Porrini E, Pourmalek F, Raju M, Ranganathan D, Rehm JT, Rein DB, Remuzzi G, Rivara FP, Roberts T, De León FR, Rosenfeld LC, Rushton L, Sacco RL, Salomon JA, Sampson U, Sanman E, Schwebel DC, Segui-Gomez M, Shepard DS, Singh D, Singleton J, Sliwa K, Smith E, Steer A, Taylor JA, Thomas B, Tleyjeh IM, Towbin JA, Truelsen T, Undurraga EA, Venketasubramanian N, Vijayakumar L, Vos T, Wagner GR, Wang M, Wang W, Watt K, Weinstock MA, Weintraub R, Wilkinson JD, Woolf AD, Wulf S, Yeh P-H, Yip P, Zabetian A, Zheng Z-J, Lopez AD, Murray CJL, AlMazroa MA, Memish ZA, (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2095–2128.
2. Girosi F, Olmsted SS, Keeler E, Burgess Hay DC, Lim Y-W, Aledort JE, Rafael ME, Ricci KA, Boer R, Hilborne L, Derose KP, Shea MV, Beighley CM, Dahl CA, Wasserman J, (2006) Developing and interpreting models to improve diagnostics in developing countries. Nature 444 Suppl: 3–8.
3. Tanimura T, Jaramillo E, Weil D, Raviglione M, Lönnroth K, (2014) Financial burden for tuberculosis patients in low- and middle-income countries: A systematic review. Eur. Respir. J. 43: 1763–1775.
4. WHO (2013) Global Tuberculosis Report 2013. 1–306.
5. Golub JE, Bur S, Cronin WA, Gange S, Baruch N, Comstock GW, Chaisson RE, (2006) Delayed tuberculosis diagnosis and tuberculosis transmission. Int. J. Tuberc. Lung Dis. 10: 24–30.
6. WHO (2013) World Malaria Report 2013. 1–178.
7. Mabey D, Peeling RW, Ustianowski A, Perkins MD, (2004) Diagnostics for the developing world. Nat. Rev. Microbiol. 2: 231–240.
8. Peeling RW, Holmes KK, Mabey D, Ronald A, (2006) Rapid tests for sexually transmitted infections (STIs): The way forward. Sex. Transm. Infect. 82 Suppl. 5: v1–v6.
9. Klarkowski D, O'Brien DP, Shanks L, Singh KP, (2014) Causes of false-positive HIV rapid diagnostic test results. Expert Rev. Anti. Infect. Ther. 12: 49–62.
10. Herring A, Ballard R, Mabey D, Peeling RW, (2006) Evaluation of rapid diagnostic tests: Syphilis. Nat. Rev. Microbiol. 4: S33–S40.
11. Vasoo S, Stevens J, Singh K, (2009) Rapid antigen tests for diagnosis of pandemic (Swine) influenza A/ H1N1. Clin. Infect. Dis. 49: 1090–1093.
12. Drain PK, Losina E, Coleman SM, Giddy J, Ross D, Katz JN, Walensky RP, Freedberg KA, Bassett IV (2014) Diagnostic accuracy of a point-of-care urine test for tuberculosis screening among newly-diagnosed HIV-infected adults: A prospective, clinic-based study. BMC Infect. Dis. 14: 110. 1–9.
13. Boelaert M, Bhattacharya S, Chappuis F, El Safi SH, Hailu A, Mondal D, Rijal S, Sundar S, Wasunna M, Peeling RW, (2007) Evaluation of rapid diagnostic tests: Visceral leishmaniasis. Nat. Rev. Microbiol. 5: S30–S39.
14. Blacksell SD, (2012) Commercial dengue rapid diagnostic tests for point-of-care application: Recent evaluations and future needs? J. Biomed. Biotechnol. 2012: 1–7.
15. Jacobs J, Barbé B, Gillet P, Aidoo M, Serra-Casas E, Van Erps J, Daviaud J, Incardona S, Cunningham J, Visser T, (2014) Harmonization of malaria rapid diagnostic tests: Best practices in labelling including instructions for use. Malar. J. 13: 505. 1–10.
16. WHO (2014) Malaria rapid diagnostic test performance. Results of WHO product testing of malaria RDTs: Round 5 (2013). World Heal. Organ. 5: 1–140.
17. WHO (2011) Good practices for selecting and procuring rapid diagnostic tests for malaria. 1–71.
18. Albertini A, Lee E, Coulibaly SO, Sleshi M, Faye B, Mationg ML, Ouedraogo K, Tsadik AG, Feleke SM, Diallo I, Gaye O, Luchavez J, Bennett J, Bell D, (2012) Malaria rapid diagnostic test transport and storage conditions in Burkina Faso, Senegal, Ethiopia and the Philippines. Malar. J. 11: 1–9.
19. Jorgensen P, Chanthap LON, Rebueno A, Tsuyuoka R, Bell D, (2006) Malaria rapid diagnostic tests in tropical climates: The need for a cool chain. Am. J. Trop. Med. Hyg. 74: 750–754.
20. Gomes LT, Tada MS, Katsuragawa TH, Póvoa MM, Viana GMR, Alecrim GC, de Santana-Filho FS, Arcanjo ARL, Couto ÁARA, Calvosa VSP, Nery AF, Fontes CJF, (2012) Low sensitivity of malaria rapid diagnostic tests stored at room temperature in the Brazilian Amazon Region. J. Infect. Dev. Ctries. 7: 243–252.
21. WHO (2006) Towards Quality Testing of Malaria Rapid Diagnostic Tests: Evidence and Methods. 1–53.
22. Chanthap L, Ariey F, Socheat D, Tsuyuoka R, Bell D, (2010) Low-technology cooling box for storage of malaria RDTs and other medical supplies in remote areas. Malar. J. 9: 31. 1–7.
23. Mikhail AFW, Leslie TJ, Mayan MI, Zekria R, Mohammad N, Hasanzai MA, Safi N, Whitty CJM, Rowland M, (2011) Field trial of three different Plasmodium vivax-detecting rapid diagnostic tests with and without evaporative cool box storage in Afghanistan. Malar. J. 10: 169. 1–15.
24. Crucitti T, Fransen K, Maharaj R, Tenywa T, Loembé MM, Murugavel KG, Mendonca K, Abdellati S, Beelaert G, van Damme L, (2010) Obtaining valid laboratory data in clinical trials conducted in resource diverse settings: Lessons learned from a microbicide phase III clinical trial. PLoS One 5: e13592.
25. Barbé B, Gillet P, Beelaert G, Fransen K, Jacobs J, (2012) Assessment of desiccants and their instructions for use in rapid diagnostic tests. Malar. J. 11: 326. 2–10.
26. Hau J, Hendriksen CFM, (2005) Refinement of polyclonal antibody production by combining oral immunization of chickens with harvest of antibodies from the egg yolk. ILAR J. 46: 294–299.
27. Lipman NS, Jackson LR, Trudel LJ, Weis-Garcia F, (2005) Monoclonal versus polyclonal antibodies: Distinguishing characteristics, applications, and information resources. ILAR J. 46: 258–268.
28. Kolberg J, Penny L, Todd J, Urdea M, (2009) An assessment of the technological issues and options for point-of-care diagnostic tests in resource-limited settings. Halteres Associates. Emeryville, CA. 1–49.
29. Benet C, Van Cutsem P, (2003) Negative purification method for the selection of specific antibodies from polyclonal antisera. Biotechniques 33: 5–8.
30. Marx V, (2013) Finding the right antibody for the job. Nat. Methods 10: 703–707.
31. Lipman NS, Jackson LR, Trudel LJ, Weis-Garcia F, (2005) Monoclonal versus polyclonal antibodies: Distinguishing characteristics, applications, and information resources. ILAR J. 46: 258–268.
32. Leow CH, Jones M, Cheng Q, Mahler S, McCarthy J, (2014) Production and characterization of specific monoclonal antibodies binding the Plasmodium falciparum diagnostic biomarker, histidine-rich protein 2. Malar. J. 13: 277. 1–12.
33. Schneider EL, Marletta MA, (2005) Heme binding to the histidine-rich protein II from Plasmodium falciparum. Biochemistry 44: 979–986.
34. Mullen LM, Nair SP, Ward JM, Rycroft AN, Henderson B, (2006) Phage display in the study of infectious diseases. Trends Microbiol. 14: 141–147.
35. Gai SA, Wittrup KD, (2007) Yeast surface display for protein engineering and characterization. Curr. Opin. Struct. Biol. 17: 467–473.
36. Rothe A, Hosse RJ, Power BE, (2006) In vitro display technologies reveal novel biopharmaceutics. FASEB J. 20: 1599–1610.
37. Fujii S, Matsuura T, Sunami T, Nishikawa T, Kazuta Y, Yomo T, (2014) Liposome display for in vitro selection and evolution of membrane proteins. Nat. Protoc. 9: 1578–1591.
38. Ferrara F, Naranjo LA, Kumar S, Gaiotto T, Mukundan H, Swanson B, Bradbury ARM, (2012) Using phage and yeast display to select hundreds of monoclonal antibodies: Application to antigen 85, a tuberculosis biomarker. PLoS One 7: e49535.
39. Tillotson BJ, de Larrinoa IF, Skinner C A, Klavas DM, Shusta EV, (2013) Antibody affinity maturation using yeast display with detergent-solubilized membrane proteins as antigen sources. Protein Eng. Des. Sel. 26: 101–112.
40. Siva AC, Kirkland RE, Lin B, Maruyama T, McWhirter J, Yantiri-Wernimont F, Bowdish KS, Xin H, (2008) Selection of anti-cancer antibodies from combinatorial libraries by whole-cell panning and stringent subtraction with human blood cells. J. Immunol. Methods 330: 109–119.
41. Traxlmayr MW, Faissner M, Stadlmayr G, Hasenhindl C, Antes B, Rüker F, Obinger C, (2012) Directed evolution of stabilized IgG1-Fc scaffolds by application of strong heat shock to libraries displayed on yeast. Biochim. Biophys. Acta. 1824: 542–549.
42. Esposito D, Chatterjee DK, (2006) Enhancement of soluble protein expression through the use of fusion tags. Curr. Opin. Biotechnol. 17: 353–358.
43. Malakhov MP, Mattern MR, Malakhova OA, Drinker M, Weeks SD, Butt TR, (2004) SUMO fusions and SUMO-specific protease for efficient expression and purification of proteins. J. Struct. Funct. Genomics 5: 75–86.
44. Cereghino JL, Cregg JM, (2000) Heterologous protein expression in the methylotrophic yeast Pichia pastoris. FEMS Microbiol. Rev. 24: 45–66.
45. Fischer B, Perry B, Sumner I, Goodenough P, (1992) A novel sequential procedure to enhance the renaturation of recombinant protein from Escherichia coli inclusion bodies. 5: 593–596.
46. Schneider EL, King DS, Marletta MA, (2005) Amino acid substitution and modification resulting from Escherichia coli expression of recombinant Plasmodium falciparum histidine-rich protein II. Biochemistry 44: 987–995.
47. Mayo Clinic (2003) The Ghost in the assay tube: Heterophile antibody interferences in immunoassays — an ever-recurring but often forgotten problem. Mayo Ref. Serv. 28: 1–8.
48. Boscato M, Stuart MC, (1988) Heterophilic antibodies: A problem for all immunoassays. Clin. Chem. 34: 27–33.
49. Spitznagel TM, Clark DS, (1993) Surface-density and orientation effects on immobilized antibodies and antibody fragments. Biotechnol. (Nature Publ. Company) 11: 825–829.
50. Storz U, (2014) Intellectual property protection. MAbs 3: 310–317.
51. Nangola S, Thongkum W, Saoin S, Ansari AA, Tayapiwatana C, (2014) An application of capsidspecific artificial ankyrin repeat protein produced in E. coli for immunochromatographic assay as a surrogate for antibody. Appl. Microbiol. Biotechnol. 98: 6095–6103.
52. Fatima A, Wang H, Kang K, Xia L, Wang Y, Ye W, Wang J, Wang X, (2014) Development of VHH antibodies against dengue virus type 2 NS1 and comparison with monoclonal antibodies for use in immunological diagnosis. PLoS One 9: e95263.
53. Trilling AK, de Ronde H, Noteboom L, van Houwelingen A, Roelse M, Srivastava SK, Haasnoot W, Jongsma MA, Kolk A, Zuilhof H, Beekwilder J, (2011) A broad set of different llama antibodies specific for a 16 kDa heat shock protein of Mycobacterium tuberculosis. PLoS One 6: e26754.
54. Tang X-L, Zhou Y-X, Wu S-M, Pan Q, Xia B, Zhang X-L, (2014) CFP10 and ESAT6 aptamers as effective Mycobacterial antigen diagnostic reagents. J. Infect. 69: 569–580.
55. Dirkzwager R, Kinghorn A, Richards J, Tanner J, (2015) APTEC: Aptamer-tethered enzyme capture as a novel rapid diagnostic test for malaria. Chem. Commun. 51: 4697–4700.
56. Griffiths K, Dolezal O, Parisi K, Angerosa J, Dogovski C, Barraclough M, Sanalla A, Casey J, González I, Perugini M, Nuttall S, Foley M, (2013) Shark variable new antigen receptor (vnar) single domain antibody fragments: Stability and diagnostic applications. Antibodies 2: 66–81.
57. Heidelberger M, Kendall FE, (1935) A quantitative theory of the precipitin reaction: A study of an azoprotein-antibody system. J. Exp. Med. 62: 467–483.
58. Gillet P, Mori M, Van Esbroeck M, Van den Ende J, Jacobs J, (2009) Assessment of the prozone effect in malaria rapid diagnostic tests. Malar. J. 8: 1–7.
59. Gillet P, Scheirlinck A, Stokx J, De Weggheleire A, Chaúque HS, Canhanga ODJ V, Tadeu BT, Mosse CDD, Tiago A, Mabunda S, Bruggeman C, Bottieau E, Jacobs J, (2011) Prozone in malaria rapid diagnostics tests: How many cases are missed? Malar. J. 10: 3–11.
60. Butch AW, Tang ME, Standage JC, (2000) Dilution protocols for detection of hook effects/prozone phenomenon. Clin. Chem. 46: 1719–1721.
61. Teles FSRR, (2011) Biosensors and rapid diagnostic tests on the frontier between analytical and clinical chemistry for biomolecular diagnosis of dengue disease: A review. Anal. Chim. Acta 687: 28–42.
62. Seidahmed OME, Mohamedein MMN, Elsir AA, Ali FT, Malik EFM, Ahmed ES, (2008) End-user errors in applying two malaria rapid diagnostic tests in a remote area of Sudan. Trop. Med. Int. Health 13: 406–409.
63. WHO (2013) Malaria Rapid Diagnostic Test Performance. Summary results of WHO product testing of malaria RDTs: Round 1–5 (2008–2013). World Heal. Organ. 1–36.
64. Banoo S, Bell D, Bossuyt P, Herring A, Mabey D, Poole F, Smith PG, Sriram N, Wongsrichanalai C, Linke R, O'Brien R, Perkins M, Cunningham J, Matsoso P, Nathanson CM, Olliaro P, Peeling RW, Ramsay A, (2010) Evaluation of diagnostic tests for infectious diseases: General principles. Nat. Rev. Microbiol. 8: S17–S29.
65. Pedersen S, (2010) How to use a rapid diagnostic test: A guide for training at a village and clinic level. WHO 1: 1–48.
66. Mudanyali O, Dimitrov S, Sikora U, Padmanabhan S, Navruz I, Ozcan A, (2012) Integrated rapid-diagnostic-test reader platform on a cellphone. Lab Chip 12: 2678–2686.
67. Shin HS, Kim CK, Shin KS, Chung HK, Heo TR, (2001) Pretreatment of whole blood for use in immunochromatographic assays for hepatitis B virus surface antigen. Clin. Diagn. Lab. Immunol. 8: 9–13.
68. Hucknall A, Rangarajan S, Chilkoti A, (2009) In pursuit of zero: Polymer brushes that resist the adsorption of proteins. Adv. Mater. 21: 2441–2446.
69. Badu-Tawiah AK, Lathwal S, Kaastrup K, Al-Sayah M, Christodouleas DC, Smith BS, Whitesides GM, Sikes HD, (2015) Polymerization-based signal amplification for paper-based immunoassays. Lab Chip 15: 655–659.
70. Bell D, Peeling RW, (2006) Evaluation of rapid diagnostic tests: Malaria. Nat. Rev. Microbiol. S34–S40.
71. Gomez-Marquez J, (2011) Design for hack in medicine: MacGyver nurses and Legos are helping us make MEDIKits for better health care. Make Magazine Ultimate Kit Guide. http://makezine.com/2012/04/03/design-for-hack-in-medicine/.
72. Bell D, Wongsrichanalai C, Barnwell JW, (2006) Ensuring quality and access for malaria diagnosis: How can it be achieved? Nat. Rev. Microbiol. 4: 682–695.
73. Zhang Y, Bai J, Ying JY, (2015) A stacking flow immunoassay for the detection of dengue-specific immunoglobulins in salivary fluid. Lab Chip 15: 1465–1471.
74. McMorrow ML, Aidoo M, Kachur SP, (2011) Malaria rapid diagnostic tests in elimination settings — can they find the last parasite? Clin. Microbiol. Infect. 17: 1624–1631.
75. Gatton ML, Cheng Q, (2002) Evaluation of the pyrogenic threshold for Plasmodium falciparum malaria in naive individuals. Am. J. Trop. Med. Hyg. 66: 467–473.
76. Dal-Bianco MP, Köster KB, Kombila UD, Kun JFJ, Grobusch MP, Ngoma GM, Matsiegui PB, Supan C, Salazar Ospina CL, Missinou MA, Issifou S, Lell B, Kremsner P, (2007) High prevalence of asymptomatic Plasmodium falciparum infection in Gabonese adults. Am. J. Trop. Med. Hyg. 77: 939–942.
77. WHO (2009) Malaria rapid diagnostic test performance. Results of WHO product testing of malaria RDTs: Round 1 (2008). World Heal. Organ. 1: 1–110.
78. Davis KM, Gibson LE, Haselton FR, Wright DW, (2014) Simple sample processing enhances malaria rapid diagnostic test performance. Analyst 139: 3026–3031.
79. Wilson S, Lane A, Rosedale R, Stanley C, (2010) Concentration of Mycobacterium tuberculosis from sputum using ligand-coated magnetic beads. Int. J. Tuberc. Lung Dis. 14: 1164–1168.
80. Chappuis F, Alirol E, D'Acremont V, Bottieau E, Yansouni CP, (2013) Rapid diagnostic tests for non-malarial febrile illness in the tropics. Clin. Microbiol. Infect. 19: 422–431.
81. Linares EM, Kubota LT, Michaelis J, Thalhammer S, (2012) Enhancement of the detection limit for lateral flow immunoassays: Evaluation and comparison of bioconjugates. J. Immunol. Methods 375: 264–270.
82. Sakurai A, Takayama K, Nomura N, Yamamoto N, Sakoda Y, Kobayashi Y, Kida H, Shibasaki F, (2014) Multi-colored immunochromatography using nanobeads for rapid and sensitive typing of seasonal influenza viruses. J. Virol. Methods 209: 62–68.
83. Leem H, Shukla S, Song X, Seunggi H, Kim M, (2014) An efficient liposome-based immunochromatographic strip assay for the sensitive detection of Salmonella typhimuium in pure culture. J. Food Saf. 34: 239–248.
84. Goryacheva IY, Lenain P, De Saeger S, (2013) Nanosized labels for rapid immunotests. TrAC — Trends Anal. Chem. 46: 30–43.
85. Imamura K, Murai K, Korehisa T, Shimizu N, Yamahira R, Matsuura T, Tada H, Imanaka H, Ishida N, Nakanishi K, (2014) Characteristics of sugar surfactants in stabilizing proteins during freeze-thawing and freeze-drying. J. Pharm. Sci. 103: 1628–1637.
86. Venkatesh AG, Sun A, Brickner H, Looney D, Hall D A, Aronoff-Spencer E, (2015) Yeast dual-affinity biobricks: Progress towards renewable whole-cell biosensors. Biosens. Bioelectron. 70: 462–468.
87. Lee J-H, Seo HS, Kwon J-H, Kim H-T, Kwon KC, Sim SJ, Cha YJ, Lee J, (2015) Multiplex diagnosis of viral infectious diseases (AIDS, hepatitis C, and hepatitis A) based on point of care lateral flow assay using engineered proteinticles. Biosens. Bioelectron. 69: 213–225.
88. Posthuma-Trumpie GA, Korf J, Van Amerongen A, (2009) Lateral flow (immuno)assay: Its strengths, weaknesses, opportunities and threats. A literature survey. Anal. Bioanal. Chem. 393: 569–582.
89. Yeo S-J, Huong DT, Hong NN, Li C-Y, Choi K, Yu K, Choi D-Y, Chong C-K, Choi HS, Mallik SK, Kim HS, Sung HW, Park H, (2014) Rapid and quantitative detection of zoonotic influenza A virus infection utilizing coumarin-derived dendrimer-based fluorescent immunochromatographic strip test (FICT). Theranostics 4: 1239–1249.
90. Cho JH, Paek SH, (2001) Semiquantitative, bar code version of immunochromatographic assay system for human serum albumin as model analyte. Biotechnol. Bioeng. 75: 725–732.
91. Dondorp AM, Desakorn V, Pongtavornpinyo W, Sahassananda D, Silamut K, (2005) Estimation of the total parasite biomass in acute falciparum malaria from plasma. PLoS Med. 2: e204.
92. Marquart L, Butterworth A, McCarthy JS, Gatton ML, (2012) Modelling the dynamics of Plasmodium falciparum histidine-rich protein 2 in human malaria to better understand malaria rapid diagnostic test performance. Malar. J. 11: 1–9.
93. Pava Z, Echeverry DF, Díaz G, Murillo C, (2010) Short report: Large variation in detection of histidine-rich protein 2 in Plasmodium falciparum isolates from Colombia. Am. J. Trop. Med. Hyg. 83: 834–837.
94. Maltha J, Gamboa D, Bendezu J, Sanchez L, Cnops L, Gillet P, Jacobs J, (2012) Rapid diagnostic tests for malaria diagnosis in the Peruvian Amazon: Impact of pfhrp2 gene deletions and cross-reactions. PLoS One 7: e43094.
95. Houzé S, Hubert V, Le Pessec G, Le Bras J, Clain J, (2011) Combined deletions of pfhrp2 and pfhrp3 genes result in plasmodium falciparum malaria false-negative rapid diagnostic test. J. Clin. Microbiol. 49: 2694–2696.
96. Baker J, Ho M-F, Pelecanos A, Gatton M, Chen N, Abdullah S, Albertini A, Ariey F, Barnwell J, Bell D, Cunningham J, Djalle D, Echeverry DF, Gamboa D, Hii J, Kyaw MP, Luchavez J, Membi C, Menard D, Murillo C, Nhem S, Ogutu B, Onyor P, Oyibo W, Wang SQ, McCarthy J, Cheng Q, (2010) Global sequence variation in the histidine-rich proteins 2 and 3 of Plasmodium falciparum: Implications for the performance of malaria rapid diagnostic tests. Malar. J. 9: 1–12.
97. Mouatcho JC, Goldring JPD, (2013) Malaria rapid diagnostic tests: Challenges and prospects. J. Med. Microbiol. 62: 1491–1505.
98. De Macedo CS, Schwarz RT, Todeschini AR, Previato JO, Mendonça-Previato L, (2010) Over-looked post-translational modifications of proteins in Plasmodium falciparum: N- and O-glycosylation — A review. 105: 949–956.
99. Lawn SD, (2012) Point-of-care detection of lipoarabinomannan (LAM) in urine for diagnosis of HIV-associated tuberculosis: A state of the art review. BMC Infect. Dis. 12: 1–12.
100. Wood R, Lawn SD, (2012) Challenges facing lipoarabinomannan urine antigen tests for diagnosing HIV-associated tuberculosis. Expert Rev. Mol. Diagn. 12: 549–551.
101. Fatima A, Wang J, (2015) Progress in the diagnosis of dengue virus infections and importance of point of care test: A Review. J. Pharm. Sci. 28: 271–280.
102. Ho M-F, Baker J, Lee N, Luchavez J, Ariey F, Nhem S, Oyibo W, Bell D, González I, Chiodini P, Gatton ML, Cheng Q, McCarthy JS, (2014) Circulating antibodies against Plasmodium falciparum histidine-rich proteins 2 interfere with antigen detection by rapid diagnostic tests. Malar. J. 13: 1–12.
103. Yen C-W, de Puig H, Tam JO, Gómez-Márquez J, Bosch I, Hamad-Schifferli K, Gehrke L, (2015) Multicolored silver nanoparticles for multiplexed disease diagnostics: Distinguishing dengue, yellow fever, and Ebola viruses. Lab Chip 15: 1638–1641.
104. Fry SR, Meyer M, Semple MG, Simmons CP, Sekaran SD, Huang JX, McElnea C, Huang CY, Valks A, Young PR, Cooper M A, (2011) The diagnostic sensitivity of Dengue rapid test assays is significantly enhanced by using a combined antigen and antibody testing approach. PLoS Negl. Trop. Dis. 5: e1199
105. Tanca A, Deligios M, Addis MF, Uzzau S, (2013) High throughput genomic and proteomic technologies in the fight against infectious diseases. J. Infect. Dev. Ctries. 7: 182–190.
106. Kashino SS, Pollock N, Napolitano DR, Rodrigues V, Campos-Neto A, (2008) Identification and characterization of Mycobacterium tuberculosis antigens in urine of patients with active pulmonary tuberculosis: An innovative and alternative approach of antigen discovery of useful microbial molecules. Clin. Exp. Immunol. 153: 56–62.
107. Young BL, Mlamla Z, Gqamana PP, Smit S, Roberts T, Peter J, Theron G, Govender U, Dheda K, Blackburn J, (2014) The identification of tuberculosis biomarkers in human urine samples. Eur. Respir. J. 43: 1719–1729.
108. Warren AD, Kwong GA, Wood DK, Lin KY, Bhatia SN, (2014) Point-of-care diagnostics for noncommunicable diseases using synthetic urinary biomarkers and paper microfluidics. Proc. Natl. Acad. Sci. U. S. A. 111: 3671–3676.
109. Xie H, Mire J, Kong Y, Chang M, Hassounah HA, Thornton CN, Sacchettini JC, Cirillo JD, Rao J, (2012) Rapid point-of-care detection of the tuberculosis pathogen using a BlaC-specific fluorogenic probe. Nat. Chem. 4: 802–809.
110. Dortet L, Poirel L, Errera C, Nordmann P, (2014) CarbAcineto NP test for rapid detection of carbapenemase-producing Acinetobacter spp. J. Clin. Microbiol. 52: 2359–2364.
111. Gillet P, Mori M, Van den Ende J, Jacobs J, (2010) Buffer substitution in malaria rapid diagnostic tests causes false-positive results. Malar. J. 9: 1–8.
112. Diggle E, Asgary R, Gore-Langton G, Nahashon E, Mungai J, Harrison R, Abagira A, Eves K, Grigoryan Z, Soti D, Juma E, Allan R, (2014) Perceptions of malaria and acceptance of rapid diagnostic tests and related treatment practises among community members and health care providers in Greater Garissa, North Eastern Province, Kenya. Malar. J. 13: 1–12.
113. Kyabayinze DJ, Asiimwe C, Nakanjako D, Nabakooza J, Counihan H, Tibenderana JK, (2010) Use of RDTs to improve malaria diagnosis and fever case management at primary health care facilities in Uganda. Malar. J. 9: 1–10.
114. Manyando C, Njunju EM, Chileshe J, Siziya S, Shiff C, (2014) Rapid diagnostic tests for malaria and health workers' adherence to test results at health facilities in Zambia. Malar. J. 13: 1.
115. D'Acremont V, Malila A, Swai N, Tillya R, Kahama-Maro J, Lengeler C, Genton B, (2010) Withholding anti-malarials in febrile children who have a negative result for a rapid diagnostic test. Clin. Infect. Dis. 51: 506–511.
116. Comoé CC, Ouattara AF, Raso G, Tanner M, Utzinger J, Koudou BG, (2012) Willingness to use a rapid diagnostic test for malaria in a rural area of central Côte d'Ivoire. BMC Public Health 12: 1–9.
117. Baiden F, Owusu-Agyei S, Okyere E, Tivura M, Adjei G, Chandramohan D, Webster J, (2012) Acceptability of rapid diagnostic test-based management of Malaria among caregivers of under-five children in rural Ghana. PLoS One 7: e45556.
118. UNITAID (2012) Diagnostic Technology Landscape. 1–36.
119. Kalluri P, Naheed A, Rahman S, Ansaruzzaman M, Faruque ASG, Bird M, Khatun F, Bhuiyan NA, Nato F, Fournier J-M, Bopp C, Breiman RF, Nair GB, Mintz ED, (2006) Evaluation of three rapid diagnostic tests for cholera: Does the skill level of the technician matter? Trop. Med. Int. Health 11: 49–55.
120. Mukanga D, Babirye R, Peterson S, Pariyo GW, Ojiambo G, Tibenderana JK, Nsubuga P, Kallander K, (2011) Can lay community health workers be trained to use diagnostics to distinguish and treat malaria and pneumonia in children? Lessons from rural Uganda. Trop. Med. Int. Health 16: 1234–1242.
121. Hasselback L, Crawford J, Chaluco T, Rajagopal S, Prosser W, Watson N, (2014) Rapid diagnostic test supply chain and consumption study in Cabo Delgado, Mozambique: Estimating stock shortages and identifying drivers of stock-outs. Malar. J. 13: 1–10.
122. “Malaria RDT Product Testing: Interactive Guide.” FIND. http://www.finddiagnostics.org/programs/malaria-afs/malaria/rdt_quality_control/product_testing/malaria-rdt-product-testing/.
123. Peeling RW, Smith PG, Bossuyt PMM, (2010) A guide for diagnostic evaluations. Nat. Rev. Microbiol. 8: S2–S6.
124. Cunningham J, (2012) Methods Manual for Product Testing of Malaria Rapid Diagnostic Tests, Atlanta, GA, USA. 1–189.
125. WHO (2011) Universal Access to Malaria Diagnostic Testing: An Operational Manual. 12: 1–160.
126. Lon CT, Alcantara S, Luchavez J, Tsuyuoka R, Bell D, (2005) Positive control wells: A potential answer to remote-area quality assurance of malaria rapid diagnostic tests. Trans. R. Soc. Trop. Med. Hyg. 99: 493–498.
127. Hansen KS, Pedrazzoli D, Mbonye A, Clarke S, Cundill B, Magnussen P, Yeung S, (2013) Willingness-to-pay for a rapid malaria diagnostic test and artemisinin-based combination therapy from private drug shops in Mukono District, Uganda. Health Policy Plan. 28: 185–196.
128. Cohen J, Dupas P, Schaner SG, (2014) Price subsidies, diagnostic tests, and targeting of malaria treatment: Evidence from a randomized controlled trial. Cambridge, MA, USA. 1–63.
129. Lubell Y, Reyburn H, Mbakilwa H, Mwangi R, Chonya S, Whitty CJM, Mills A, (2008) The impact of response to the results of diagnostic tests for malaria: Cost-benefit analysis. BMJ 336: 202–205.
130. Cook J, Xu W, Msellem M, Vonk M, Bergstrom B, Gosling R, Al-Mafazy A-W, McElroy P, Molteni F, Abass A K, Garimo I, Ramsan M, Ali A, Martensson A, Bjorkman A, (2014) Mass Screening and Treatment on the Basis of Results of a Plasmodium falciparum-Specific Rapid Diagnostic Test Did Not Reduce Malaria Incidence in Zanzibar. J. Infect. Dis. 211: 1476–1483.
131. Chin CD, Laksanasopin T, Cheung YK, Steinmiller D, Linder V, Parsa H, Wang J, Moore H, Rouse R, Umviligihozo G, Karita E, Mwambarangwe L, Braunstein SL, van de Wijgert J, Sahabo R, Justman JE, El-Sadr W, Sia SK, (2011) Microfluidics-based diagnostics of infectious diseases in the developing world. Nat. Med. 17: 1015–1019.
132. Byrnes S, Thiessen G, Fu E, (2013) Progress in the development of paper-based diagnostics for low-resource point-of-care settings. Bioanalysis 5: 2821–2836.
133. Yetisen AK, Akram MS, Lowe CR, (2013) Paper-based microfluidic point-of-care diagnostic devices. Lab Chip 13: 2210–2251.
134. Kulinsky L, Noroozi Z, Madou M, (2013) Thread-based devices for low-cost diagnostics. In Methods in Molecular Biology, pp. 3–23.
135. Fu E, Liang T, Spicar-Mihalic P, Houghtaling J, Ramachandran S, Yager P, (2012) Two-dimensional paper network format that enables simple multistep assays for use in low-resource settings in the context of malaria antigen detection. Anal. Chem. 84: 4574–4579.
136. Binz HK, Amstutz P, Plückthun A, (2005) Engineering novel binding proteins from nonimmunoglobulin domains. Nat. Biotechnol. 23: 1257–1268.
137. Laksanasopin T, Guo TW, Nayak S, Sridhara AA, Xie S, Olowookere OO, Cadinu P, Meng F, Chee NH, Kim J, Chin CD, Munyazesa E, Mugwaneza P, Rai AJ, Mugisha V, Castro AR, Steinmiller D, Linder V, Justman JE, Nsanzimana S, Sia SK, (2015) A smartphone dongle for diagnosis of infectious diseases at the point of care. Sci. Transl. Med. 7: 273re1.